LAKE FOREST, Calif.--(BUSINESS WIRE)--I-Flow Corporation (NASDAQ:IFLO) announced today that results of its ON-Q prospective human study in colorectal surgery will be presented on Tuesday, September 18th at the world-renowned 47th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC) in Chicago, Illinois.
